Core Laboratories N.V.
CLBNYSEEnergy● Active
$13.37
$-0.07(-0.48%)
Market Cap$616082155
P/E Ratio—
52W High$20.36
52W Low$9.72
Core Laboratories N.V. (CLB) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLB · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.03B | $0.03B | $0.04B | $0.02B | $0.02B |
| Depreciation & Amort. | $0.01B | $0.01B | $0.02B | $0.02B | $0.02B |
| Stock-Based Comp. | $0.01B | $0.00B | $0.01B | $0.01B | $0.02B |
| Change in Working Capital | ($0.01B) | $0.01B | ($0.03B) | ($0.03B) | ($0.02B) |
| Net Cash from Operations | $0.04B | $0.06B | $0.02B | $0.02B | $0.04B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.01B) |
| Dividends Paid | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Debt Issued / Repaid | ($0.02B) | ($0.04B) | ($0.01B) | ($0.01B) | ($0.07B) |
| Net Cash from Financing | ($0.03B) | ($0.05B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.02B | $0.04B | $0.01B | $0.01B | $0.02B |
| FCF Margin %(computed) | 4.29% | 8.28% | 2.79% | 3.01% | 4.90% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Core Laboratories N.V. data
About Core Laboratories N.V. (CLB) Cash Flow Statement
Core Laboratories N.V. generated operating cash flow of $0.04B and free cash flow of $0.02B for 2025 — a FCF margin of 4.29%. Capital expenditure was ($0.01B).
Frequently asked questions
CLB · 4 questionsCore Laboratories N.V. generated free cash flow of $0.02B for 2025, down 47.9% year-over-year.
CLB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10